Related Articles
The pan‑deacetylase inhibitor panobinostat modulates the expression of epithelial‑mesenchymal transition markers in hepatocellular carcinoma models
Different cascades in the signaling pathway of two vascular endothelial growth factor (VEGF) receptors for the VEGF-mediated murine hepatocellular carcinoma development
γ-secretase inhibitor up-regulates vascular endothelial growth factor receptor-2 and endothelial nitric oxide synthase
Cytohesin-2 as a novel prognostic marker for hepatocellular carcinoma
Hepatocellular carcinoma cells surviving doxorubicin treatment exhibit increased migratory potential and resistance to doxorubicin re-treatment in vitro